Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: No additional benefit of combination with lamivudine

Monika van Zonneveld, Pieter E. Zondervan, Yilmaz Cakaloglu, Christopher Simon, Ulus S. Akarca, Thomas M K So, Hajo J. Flink, Robert A. de Man, Solko W. Schalm, Harry L A Janssen, H. G M Niesters, B. Hansen, B. C M Vroom, C. M J van Nieuwkerk, R. A. de Vries, J. Jansen, J. Drenth, S. J. van den Hazel, J. W. den Ouden-Muller, A. C. TanD. M. Adler, P. Michielsen, H. van Vlierberghe, F. Nevens, J. Delwaide, J. Henrion, S. Zeuzem, G. Gerken, S. Bein, U. Treichel, J. Trojan, M. P. Manns, J. Hadem, J. Niederau, M. R. Buhl, I. M. Hansen, K. Krogsgaard, J. Cianciara, J. Jablonska, J. Kozlowska, D. Prokopowicz, R. Flisiak, T. Mach, M. Buti, A. Valdes, R. Esteban, M. Rodriguez, M. Garcia Espiga, A. Andriulli, G. Stornaiulo, G. B. Gaeta, G. Montalto, F. D'Antona, G. E. Kitis, P. Xiarchos Panagiotis, N. C. Tassopoulos, G. Ersöz, S. Karayalcin, C. Yurdayin, H. Bozkaya, H. Simsek, Y. Balaban, H. Senturk, F. Tabak, Y. Lurie, J. Heathcote, S. V. Feinman, S. Greenbloom, D. A. Sulaiman, R. Guan, I. Merican

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: No additional benefit of combination with lamivudine'. Together they form a unique fingerprint.

Medicine & Life Sciences